Oncolytics Biotech buy Raymond James
Start price
04.04.24
/
50%
€1.61
Target price
04.04.25
€2.76
Performance (%)
-
End price
05.04.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Oncolytics Biotech | - | - | - |
| iShares Core DAX® | 2.573% | 3.502% | 8.408% |
| iShares Nasdaq 100 | 4.858% | 0.654% | 28.383% |
| iShares Nikkei 225® | 5.590% | -0.246% | 52.915% |
| iShares S&P 500 | 3.250% | 2.083% | 24.370% |
Comments by Raymond_James for this prediction
In the thread Oncolytics Biotech diskutieren
Oncolytics Biotech Inc. (NASDAQ: ONCY) is now covered by analysts at Raymond James. They set an "outperform" rating and a $3.00 price target on the stock.
Ratings data for ONCY provided by MarketBeat
In the thread Trading Oncolytics Biotech
Die von Raymond_James gewählte maximale Laufzeit wurde überschritten

